One proposed mechanism underlying this therapeutic effect involves the SIAH2 gene, identified in our study as a potential disease predictor for systemic disease-associated uveiti, which encodes an E3 ubiquitin-protein ligase that modulates the JAK-STAT pathway (89), by regulating the stability and activity of proteins involved in this pathway. This evidence concerns the gene UBE2E3 and uveitis.